Composite lacrimal insert and related methods

• US 9,132,088 B2
• Filed: 04/29/2009
• Issued: 09/15/2015
• Est. Priority Date: 04/30/2008
• Status: Active Grant

• Current Assignee: Mati Therapeutics, Inc
• Original Assignee: Mati Therapeutics, Inc
• Inventors: Sim, Sylvie, Jain, Rachna, Farinas, Kathleen
• Primary Examiner(s): Kwon, Brian-Yong
• Assistant Examiner(s): Stevens, Mark V
• Application Number:
  US12/432,553
• Publication Number:
  US 20100034870A1
• Time in Patent Office: 2,330 Days
• US Class Current: 1/1
• CPC Class Codes: A61F 9/0008 Introducing ophthalmic products into the ocular cavity or retaining products therein putting in contact lenses A61F9/0061; introducing or retaining media in cavities of the body in general A61M31/00
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61K 47/34 Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers A61K47/10 takes precedence
• CPC Class Codes: A61K 9/0051 Ocular inserts, ocular implants
• CPC Class Codes: A61L 31/06 obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/041 takes precedence
• CPC Class Codes: A61L 31/145 Hydrogels or hydrocolloids
• CPC Class Codes: A61L 31/16 Biologically active materials, e.g. therapeutic substances A61L31/047 takes precedence
• CPC Class Codes: A61P 27/02 Ophthalmic agents
• CPC Class Codes: A61P 27/06 Antiglaucoma agents or miotics
• CPC Class Codes: A61P 27/14 Decongestants or antiallergics

Abstract

Lacrimal implants, methods of making lacrimal implants, and methods of treating ocular, respiration or other diseases or disorders using lacrimal implants are disclosed.

Claims

1. A lacrimal implant configured to be inserted into a lacrimal canaliculus of a patient comprising:

a unitary implant body, including first and second portions defining a single longitudinal axis, wherein the unitary body is formed from a substantially non-swelling polymer comprising one or more of a polyurethane polymer, a polyurethane copolymer, or silicone,

the first portion extending from a proximal end of the implant body, the first portion having a first diameter, wherein the first portion includes a cavity extending inward from the proximal end of the first portion, the cavity having a first supply of a first active agent for release to the eye when the lacrimal implant is implanted at least partially into the lacrimal canaliculus of the patient, and

the second portion comprising a distal end portion of the implant body and extending from a distal end of the first portion, the second portion having a second diameter less than the first diameter; and

an expandable retention member fully enveloping the second portion of the implant body, the expandable retention member configured to swell via absorption of an aqueous medium after insertion into the lacrimal canaliculus so as to retain the implant body within the lacrimal canaliculus.

2. The lacrimal implant of claim 1, wherein the substantially non-swelling polymer comprises silicone.

3. The lacrimal implant of claim 1, wherein the expandable retention member is a hydrogel-forming polyurethane polymer or co-polymer.

4. The lacrimal implant of claim 1, wherein the first supply includes a solid matrix comprising a mixture of silicone and the first active agent.

5. The lacrimal implant of claim 1, further comprising a second supply configured to provide a release of the second active agent to one or both of a lacrimal canaliculus wall or a nasolacrimal system after contact with an aqueous medium.

6. A kit comprising the lacrimal implant of claim 1, and an instruction for using the lacrimal implant to treat an eye disease.

7. The lacrimal implant of claim 1, wherein the second portion further includes one or more arm members extending from an outer surface thereof, and wherein the expandable retention member is coupled over the one or more arm members of the second portion.

8. The lacrimal implant of claim 7, wherein the one or more arm members are shaped as disks having a greater cross-sectional size than an adjacent section of the second portions.

9. The lacrimal implant of claim 7, wherein one or more of the one or more arm members have a hook shape.

10. The lacrimal implant of claim 7, wherein the one or more arm members form a balloon-shape and form a void therein that receives a portion of the expandable retention member.

11. The lacrimal implant of claim 1, wherein the second portion further comprises an angled portion having a first segment extending along a first axis coincident with an axis of the first portion and a second segment extending a long a second axis that is angled relative to the first axis.

12. The lacrimal implant of claim 1, wherein the expandable retention member, when coupled over the second portion of the implant body and prior to expansion, comprises an outer diameter that is the same as the first diameter of the first portion.

13. The lacrimal implant of claim 1, wherein the distal end of the second portion further includes one or more arm members extending from an outer surface thereof, and wherein the expandable retention member is coupled over the one or more arm members of the second portion and an area of the second portion between the proximal end of the second portion and the one or more arm members.

14. The lacrimal implant of claim 1, wherein the proximal end of the first portion further includes a head portion extending 360°

around the proximal end of the first portion, the head portion being configured to seat against or neat a punctal opening when the implant body is implanted into the lacrimal canaliculus of the patient.